Vivani Medical, Inc.
VANI
$0.99
-$0.02-1.98%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.11M | 2.17M | 2.50M | 1.51M | 2.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.31M | 5.68M | 6.23M | 6.22M | 7.14M |
| Operating Income | -6.31M | -5.68M | -6.23M | -6.22M | -7.14M |
| Income Before Tax | -6.04M | -5.36M | -6.04M | -6.03M | -6.78M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.04M | -5.36M | -6.04M | -6.03M | -6.78M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.04M | -5.36M | -6.04M | -6.03M | -6.78M |
| EBIT | -6.31M | -5.68M | -6.23M | -6.22M | -7.14M |
| EBITDA | -6.20M | -5.58M | -6.13M | -6.12M | -7.07M |
| EPS Basic | -0.11 | -0.10 | -0.12 | -0.12 | -0.13 |
| Normalized Basic EPS | -0.07 | -0.06 | -0.07 | -0.07 | -0.08 |
| EPS Diluted | -0.11 | -0.10 | -0.12 | -0.12 | -0.13 |
| Normalized Diluted EPS | -0.07 | -0.06 | -0.07 | -0.07 | -0.08 |
| Average Basic Shares Outstanding | 55.25M | 55.02M | 52.20M | 51.03M | 50.84M |
| Average Diluted Shares Outstanding | 55.25M | 55.02M | 52.20M | 51.03M | 50.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
